Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
NCT:NCT07548164 · RECRUITING
广告
NCT编号NCT07548164
状态RECRUITING
开始日期2026-04-16
完成时间2029-04-16
SponsorMemorial Sloan Kettering Cancer Center (OTHER)
First posted
Last updated
简要摘要
In this study the investigators will find out whether the use of a new type of boost approach called irreversible electroporation (IRE) is as effective as the standard boost approach of radiation therapy for participants with intermediate-risk prostate cancer receiving standard stereotactic body radiotherapy (SBRT).
官方来源
在 ClinicalTrials.gov 上查看 →数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。